Delta 9 Cannabis Inc.
DLTNFOTCHealthcare
$0.01
$-0.00(-1.95%)
Market Cap$3039509
P/E Ratio—
52W High$0.02545
52W Low$0.0069
Delta 9 Cannabis Inc. (DLTNF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DLTNF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $71.07M | $63.23M | $62.29M | $52.05M | $31.77M |
| Cost of Revenue | $56.62M | $52.35M | $44.97M | $34.05M | $15.36M |
| Gross Profit | $14.44M | $10.88M | $17.32M | $18.00M | $16.40M |
| Gross Margin %(computed) | 20.33% | 17.21% | 27.80% | 34.58% | 51.63% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $15.44M | $19.21M | $8.49M | $9.35M | $9.77M |
| Total Operating Expenses | $27.94M | $31.14M | $24.96M | $20.77M | $18.60M |
| Operating Income | ($13.49M) | ($20.26M) | ($7.64M) | ($2.08M) | ($2.07M) |
| Operating Margin %(computed) | -18.99% | -32.04% | -12.26% | -3.99% | -6.53% |
| Interest Income | $0.02M | $0.12M | $0.03M | $0.04M | $0.06M |
| Interest Expense | $6.81M | $6.51M | $3.90M | $3.20M | $1.81M |
| Income Before Tax | ($16.64M) | ($27.84M) | ($11.54M) | ($5.08M) | $13.52M |
| Income Tax Expense | $0.00M | $0.00M | ($0.40M) | $0.40M | $1.65M |
| Net Income | ($17.52M) | ($28.11M) | ($11.14M) | ($5.49M) | $13.74M |
| Net Margin %(computed) | -24.65% | -44.46% | -17.89% | -10.54% | 43.27% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.10 | $-0.22 | $-0.11 | $-0.06 | $0.16 |
| Wtd Avg Shares | 175.15M | 126.07M | 103.34M | 89.43M | 87.30M |
| EBITDA | ($1.04M) | ($13.39M) | ($1.32M) | $3.22M | $1.47M |
| EBITDA Margin %(computed) | -1.47% | -21.18% | -2.11% | 6.20% | 4.63% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more Delta 9 Cannabis Inc. data
About Delta 9 Cannabis Inc. (DLTNF) Income Statement
Delta 9 Cannabis Inc. (DLTNF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, DLTNF reported revenue of $0.07B, gross profit of $0.01B (gross margin 20.33%), and net income of ($0.02B) — a net profit margin of -24.65%.
Frequently asked questions
DLTNF · 4 questionsDelta 9 Cannabis Inc. (DLTNF) reported revenue of $0.07B for 2023, up 12.4% year-over-year.
DLTNF revenueDLTNF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09